Management of Chondral Lesions of the Knee: Analysis of Trends and Short-Term Complications Using the National Surgical Quality Improvement Program Database.


Journal

Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association
ISSN: 1526-3231
Titre abrégé: Arthroscopy
Pays: United States
ID NLM: 8506498

Informations de publication

Date de publication:
01 2019
Historique:
received: 26 03 2018
revised: 27 07 2018
accepted: 31 07 2018
pubmed: 27 11 2018
medline: 21 1 2020
entrez: 27 11 2018
Statut: ppublish

Résumé

To provide updated surgical trends of cartilage procedures differentiated by the classic groups of palliative, repair, and restorative modalities. The American College of Surgeons National Surgical Quality Improvement Program database was queried from 2010-2016 for the following cartilage procedures: chondroplasty, microfracture, arthroscopic osteochondral autograft or allograft transplantation, open osteochondral autograft or allograft transplantation, and autologous chondrocyte implantation. Demographic variables and short-term (30-day) complications were analyzed with 1-way analysis of variance and post hoc analysis. Linear regression analysis was performed to analyze trends over time. A total of 15,609 procedures performed between 2010 and 2016 were analyzed. On average, 342.2 ± 27.9 cartilage procedures were performed per 100,000 operations. There was a linear increase in the management of overall cartilage procedures per 100,000 operations (P = .002). There were also linear increases in arthroscopic osteochondral autograft transplantation, arthroscopic osteochondral allograft transplantation, open osteochondral autograft transplantation, open osteochondral allograft transplantation, and autologous chondrocyte implantation (P < .001, P = .037, P = .001, P = .006, and P = .002, respectively). Meniscectomy was the most frequently performed concomitant procedure (9.7%-64.2% of cases). Chondroplasty and microfracture showed no change in frequency over time (P = .140 and P = .720, respectively). The overall complication rate was 2.1% for chondroplasty, 1.4% for microfracture, 1.8% for arthroscopic osteochondral autograft transplantation, 1.0% for arthroscopic osteochondral allograft transplantation, 1.4% for open osteochondral autograft transplantation, 1.1% for open osteochondral allograft transplantation, and 0.75% for autologous chondrocyte implantation. Deep vein thrombosis was the most common complication, occurring in 0.4% to 1.0% of cases. No statistically significant difference was found in complication rates between procedures (P = .105). Cartilage restoration is becoming an increasingly popular modality to address chondral defects. Minimal complication rates suggest that these procedures may be safely performed concomitantly with other interventions. Level IV, retrospective database analysis.

Identifiants

pubmed: 30473458
pii: S0749-8063(18)30670-4
doi: 10.1016/j.arthro.2018.07.049
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

138-146

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.

Auteurs

Anirudh K Gowd (AK)

Rush University Medical Center, Chicago, Illinois, U.S.A.

Gregory L Cvetanovich (GL)

Department of Orthopaedics, The Ohio State University Wexner Medical Center, Columbus, Ohio, U.S.A.

Joseph N Liu (JN)

Department of Orthopaedic Surgery, Loma Linda University Medical Center, Loma Linda, California, U.S.A.

David R Christian (DR)

Rush University Medical Center, Chicago, Illinois, U.S.A.

Brandon C Cabarcas (BC)

Rush University Medical Center, Chicago, Illinois, U.S.A.

Michael L Redondo (ML)

Rush University Medical Center, Chicago, Illinois, U.S.A.

Nikhil N Verma (NN)

Rush University Medical Center, Chicago, Illinois, U.S.A.. Electronic address: Nikhil.Verma@rushortho.com.

Adam B Yanke (AB)

Rush University Medical Center, Chicago, Illinois, U.S.A.

Brian J Cole (BJ)

Rush University Medical Center, Chicago, Illinois, U.S.A.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH